KEGG   NETWORK: N01165
Entry
N01165                      Network                                
Name
PDL/PD1-SHP-PI3K signaling pathway
Definition
(PDL1,PDL2) -> PDCD1 -> SHP1/2 -| PI3Kdelta
  Expanded
(29126,80380) -> 5133 -> (5777,5781) -| (5293+(5295,5296,8503))
Class
nt06537 TCR/BCR signaling
Type
Reference
Pathway
hsa04660  T cell receptor signaling pathway
Gene
29126  CD274; CD274 molecule
80380  PDCD1LG2; programmed cell death 1 ligand 2
5133  PDCD1; programmed cell death 1
5777  PTPN6; protein tyrosine phosphatase non-receptor type 6
5781  PTPN11; protein tyrosine phosphatase non-receptor type 11
5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1
5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2
8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3
Reference
  Authors
Sharpe AH, Pauken KE
  Title
The diverse functions of the PD1 inhibitory pathway.
  Journal
Nat Rev Immunol 18:153-167 (2018)
DOI:10.1038/nri.2017.108
Reference
  Authors
Buchanan CM, Lee KL, Shepherd PR
  Title
For Better or Worse: The Potential for Dose Limiting the On-Target Toxicity of PI 3-Kinase Inhibitors.
  Journal
Biomolecules 9:biom9090402 (2019)
DOI:10.3390/biom9090402
Reference
  Authors
McBride MA, Patil TK, Bohannon JK, Hernandez A, Sherwood ER, Patil NK
  Title
Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression.
  Journal
Front Immunol 11:624272 (2020)
DOI:10.3389/fimmu.2020.624272
Reference
  Authors
Chinai JM, Janakiram M, Chen F, Chen W, Kaplan M, Zang X
  Title
New immunotherapies targeting the PD-1 pathway.
  Journal
Trends Pharmacol Sci 36:587-95 (2015)
DOI:10.1016/j.tips.2015.06.005
LinkDB

DBGET integrated database retrieval system